Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Longitudinal Assessment of Biomarkers in ALS: Discriminative Biomarkers for Disease Progression and Survival.
Journal: Annals of clinical and translational neurology
Published: February 12, 2026
Peripheral immune profiling in frontotemporal dementia.
Journal: Brain communications
Published: September 23, 2025
iS2C2: a cointelligent platform for mechanistic discovery of disease cellular crosstalk.
Journal: Signal transduction and targeted therapy
Published: May 06, 2025
Low-dose interleukin-2 in patients with mild to moderate Alzheimer's disease: a randomized clinical trial.
Journal: Alzheimer's research & therapy
Published: March 10, 2025
Peripheral monocyte transcriptional signatures of inflammation and oxidative stress in Parkinson's disease.
Journal: Frontiers in immunology
Published: February 04, 2025
A phase 1 proof-of-concept study evaluating safety, tolerability, and biological marker responses with combination therapy of CTLA4-Ig and interleukin-2 in amyotrophic lateral sclerosis.
Journal: Frontiers in neurology
Published: April 09, 2024
Brain inflammation co-localizes highly with tau in mild cognitive impairment due to early-onset Alzheimer's disease.
Journal: Brain : a journal of neurology
Published: February 17, 2024
A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease.
Journal: Translational neurodegeneration
Published: August 02, 2023
Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer's disease.
Journal: Acta neuropathologica communications
Published: September 12, 2022
Extracellular Vesicles Derived From Ex Vivo Expanded Regulatory T Cells Modulate In Vitro and In Vivo Inflammation.
Journal: Frontiers in immunology
Published: February 14, 2022
Tregs Attenuate Peripheral Oxidative Stress and Acute Phase Proteins in ALS.
Journal: Annals of neurology
Published: November 23, 2021
Serum programmed cell death proteins in amyotrophic lateral sclerosis.
Journal: Brain, behavior, & immunity - health
Published: November 17, 2020
Last Updated: 09/26/2026